The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.

Advances in mutation testing for molecular-targeted cancer therapies have led to the increased use of archived formalin-fixed paraffin-embedded (FFPE) tumors. However, DNA extracted from FFPE tumors (FFPE DNA) is problematic for mutation testing, especially for amplicon-based massively parallel sequencing (MPS), owing to DNA fragmentation and artificial C:G > T:A single nucleotide variants (SNVs) caused by deamination of cytosine to uracil. Therefore, to reduce artificial C:G > T:A SNVs in amplicon-based MPS using FFPE DNA, we evaluated the efficacy of uracil DNA glycosylase (UDG) pretreatment, which can eliminate uracil-containing DNA molecules, with 126 archived FFPE esophageal cancer specimens. We also examined the association between the frequency of C:G > T:A SNVs and DNA quality, as assessed by a quantitative PCR (qPCR)-based assay. UDG pretreatment significantly lowered the frequency of C:G > T:A SNVs in highly fragmented DNA (by approximately 60%). This effect was not observed for good- to moderate-quality DNA, suggesting that a predictive assay (i.e., DNA quality assessment) needs to be performed prior to UDG pretreatment. These results suggest that UDG pretreatment is efficacious for mutation testing by amplicon-based MPS with fragmented DNA from FFPE samples.

[1]  S. Jewell,et al.  Copyright © American Society for Investigative Pathology Review Effect of Fixatives and Tissue Processing on the Content and Integrity of Nucleic Acids , 2022 .

[2]  Rita T. Lawlor,et al.  DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples , 2013, PloS one.

[3]  M. Ladanyi,et al.  Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method , 2007, Clinical Cancer Research.

[4]  A. von Haeseler,et al.  DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA. , 2001, Nucleic acids research.

[5]  O. Griffith,et al.  COSMIC (Catalogue of Somatic Mutations in Cancer) , 2014 .

[6]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[7]  E. Lander,et al.  Lessons from the Cancer Genome , 2013, Cell.

[8]  Y. Yatabe,et al.  Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer. , 2010, Translational research : the journal of laboratory and clinical medicine.

[9]  Adam Auton,et al.  The 1000 Genomes Project , 2015 .

[10]  J. Fairley,et al.  Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. , 2012, Current drug targets.

[11]  David M. Thomas,et al.  Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing , 2014, BMC Medical Genomics.

[12]  R. Tothill,et al.  Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours , 2013, Scientific Reports.

[13]  M. Hidalgo,et al.  A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: a morphology-based approach in colorectal carcinoma. , 2010, The Journal of molecular diagnostics : JMD.

[14]  Richard Simon,et al.  Implementing personalized cancer genomics in clinical trials , 2013, Nature Reviews Drug Discovery.

[15]  Marilyn M. Li,et al.  Clinical application of amplicon-based next-generation sequencing in cancer. , 2013, Cancer genetics.

[16]  A. McKenna,et al.  Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.

[17]  Toshihiro Tanaka.  The International HapMap Project , 2003, Nature.

[18]  F. Pontén,et al.  A high frequency of sequence alterations is due to formalin fixation of archival specimens. , 1999, The American journal of pathology.

[19]  Adam C. Marko,et al.  Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies , 2013, Genome Medicine.

[20]  John D Pfeifer,et al.  Comparison of clinical targeted next-generation sequence data from formalin-fixed and fresh-frozen tissue specimens. , 2013, The Journal of molecular diagnostics : JMD.

[21]  Tomas Szemes,et al.  Fragmentation of DNA affects the accuracy of the DNA quantitation by the commonly used methods , 2013, Biological Procedures Online.

[22]  H. Kantarjian,et al.  Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring , 2014, Haematologica.

[23]  Alexander Dobrovic,et al.  Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase , 2012, Oncotarget.

[24]  J. Baselga,et al.  Impact of Genomics on Personalized Cancer Medicine , 2012, Clinical Cancer Research.

[25]  J. Rossi,et al.  Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[26]  Jason Li,et al.  Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates. , 2013, Clinical chemistry.